Injectable healing protocol: 23 mg daily (upper end of range), systemic injection - not into the wound itself - daily until the wound resolves, plus 12 weeks maintenance Topical healing protocol: 2 %4 % in a wound-appropriate vehicle applied 23 times daily to wound margins (never into an open, actively bleeding wound) under clinician supervision Stacking: GHK-Cu pairs exceptionally well with BPC-157 and TB-500 - the so-called GLOW stack - for complex healing cases
Intermediate Cu(II)-thiolate species in the reduction of Cu(II)GHK by glutathione: A handy chelate for biological Cu(II) reduction
Scientific research has demonstrated that GHK-Cu can upregulate or downregulate over 30 human genes associated with: Tissue repair Cell growth Inflammatory control This gene-modulating capability allows GHK-Cu to function at a deeper cellular level , yielding more sustained and significant results compared to peptides that act only on the surface via receptor binding (Pickart & Margolina, 2012)
In addition, the Supporting Factors such as sleep and hydration will materially affect results
Dermal Papilla Cell Proliferation and Anti-Apoptosis Dermal papilla cells (DPCs) are the signaling hub of the hair follicle
Liposomes as Carriers of GHK-Cu Tripeptide for Cosmetic Applications